Skip to main content

Subcutaneous immunoglobulin therapy

Subcutaneous immunoglobulin (SCIg) therapy delivers antibody-rich immunoglobulin under the skin to help people with immune deficiencies.

What is SCIg?

SCIg is immunoglobulin made from plasma (the liquid part of blood containing important proteins like antibodies) that is administered subcutaneously.

Immunoglobulins (commonly known as antibodies) are used to treat people who are unable to make enough of their own, or their antibodies do not work properly. 

In Australia immunoglobulin therapy has mostly been intravenous, given via a drip into the vein, but it’s also available as SCIg (an infusion into the fatty tissue under the skin) which may be more convenient and beneficial for patients.

Benefits of SCIg

  • Treatment can often be given at home
  • Greater flexibility and independence, many patients find SCIg easier to fit into their normal routine and daily life.
  • Fewer hospital visits
  • More stable immunoglobulin levels
  • Reduced “wear off” effect between treatments
  • Treatment can often continue while travelling
  • Many patients experience fewer side effects compared to IVIg

How long does treatment take?

Most SCIg infusions take approximately 1 hour, depending on your treatment plan and infusion rate.

Your healthcare team will advise you how often your SCIg treatment is required.

For more information about SCIg therapy, download the information sheet below. 

SCIg information sheet

DOCX - 712.14 KB
Download
<svg class="w-[82px] h-[82px] md:w-[104px] md:h-[104px]" width="104" height="104" viewBox="0 0 104 104" fill="none" xmlns="http://www.w3.org/2000/svg"> <rect width="104" height="104" rx="8" fill="black" fill-opacity="0.75"/> <path d="M46 40H52V64H46V40Z M56 40H62V64H56V40Z" fill="white"/> </svg>

Contact

To contact the SCIg liaison, call 0482 112 600 (24hr support)

In the case of a life threatening emergency, call 000.
Emergency